• 1
    Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767811.
  • 2
    Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997; 9:106.
  • 3
    Rughetti A, Biffoni M, Sabbatucci M et al. Transfected human dendritic cells to induce antitumor immunity. Gene Ther 2000; 7:145866.
  • 4
    Kirk CJ & Mule JJ. Gene-modified dendritic cells for use in tumor vaccines. Hum Gene Ther 2000; 11:797806.DOI: 10.1089/10430340050015419
  • 5
    Heemskerk MH, Hooijberg E, Ruizendaal JJ, Van Der Weide MM, Kueter E, Bakker AQ, Schumacher TN, Spits H. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells. Cell Immunol 1999; 195:107.DOI: 10.1006/cimm.1999.1520
  • 6
    Ferlazzo G, Wesa A, Wei WZ, Galy A. Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells. J Immunol 1999; 163:3597604.
  • 7
    Ratta M, Rondelli D, Fortuna A et al. Generation and functional characterization of human dendritic cells derived from CD34 cells mobilized into peripheral blood: comparison with bone marrow CD34+ cells. Br J Haematol 1998; 101:75665.DOI: 10.1046/j.1365-2141.1998.00771.x
  • 8
    Reid CD, Stackpoole A, Meager A, Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol 1992; 149:26818.
  • 9
    Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol 1992; 52:27481.
  • 10
    Kiertscher SM & Roth MD. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J Leukoc Biol 1996; 59:20818.
  • 11
    Zhou LJ & Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996; 93:258892.DOI: 10.1073/pnas.93.6.2588
  • 12
    Reeves ME, Royal RE, Lam JS, Rosenberg SA, Hwu P. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res 1996; 56:56727.
  • 13
    Sato K, Nagayama H, Takahashi TA. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells. Cryobiology 1998; 37:36271.DOI: 10.1006/cryo.1998.2136
  • 14
    Szabolcs P, Moore MA, Young JW. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol 1995; 154:585161.
  • 15
    Strunk D, Rappersberger K, Egger C et al. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood 1996; 87:1292302.
  • 16
    Garbe A, Köhler G, Schulz G, Lindemann A. Serum-free culture conditions for the in vitro generation of dendritic cells from peripheral blood CD34 positive progenitor cells of human adults [Abstract no. 1519, American Society of Hematology, 40th annual meeting]. Blood 1998; 92:369a.
  • 17
    Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 1996; 196:12135.DOI: 10.1016/0022-1759(96)00079-8
  • 18
    Bello-Fernandez C, Matyash M, Strobl H et al. Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions. Hum Gene Ther 1997; 8:16518.
  • 19
    Ardeshna KM, Corney CP, Ings SJ, Watts MJ, Linch DC, Devereux S. A clinically applicable method for the ex vivo generation of antigen-presenting cells from CD34+ progenitors. Vox Sang 2000; 79:4652.
  • 20
    Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90:324587.
  • 21
    Van Gool SW, Vermeiren J, Rafiq K, Lorr K, De Boer M, Ceuppens JL. Blocking CD40–CD154 and CD80/CD86–CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production. Eur J Immunol 1999; 29:236775.DOI: 10.1002/(sici)1521-4141(199908)29:08<2367::aid-immu2367>;2-v
  • 22
    Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995; 9:48496.
  • 23
    Davis TA, Saini AA, Blair PJ et al. Phorbol esters induce differentiation of human CD34+ hemopoietic progenitors to dendritic cells: evidence for protein kinase C-mediated signaling. J Immunol 1998; 160:368997.
  • 24
    St. Louis DC, Woodcock JB, Fransozo G et al. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model. J Immunol 1999; 162:323748.
  • 25
    Glimm H, Flugge K, Mobest D et al. Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium. Hum Gene Ther 1998; 9:7718.
  • 26
    Caux C, Saeland S, Favre C, Duvert V, Mannoni P, Banchereau J. Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. Blood 1990; 75:22928.
  • 27
    Rosenzwajg M, Canque B, Gluckman JC. Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood 1996; 87:53544.
  • 28
    Brossart P, Wirths S, Stuhler G, Reichardt VL, Kanz L, Brugger W. Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 2000; 96:31028.
  • 29
    Klein C, Bueler H, Mulligan RC. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. J Exp Med 2000; 191:1699708.
  • 30
    Luft T, Pang KC, Thomas E et al. A serum-free culture model for studying the differentiation of human dendritic cells from adult CD34+ progenitor cells. Exp Hematol 1998; 26:489500.
  • 31
    Winzler C, Rovere P, Rescigno M et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997; 185:31728.
  • 32
    Flores-Romo L, Bjorck P, Duvert V, Van Kooten C, Saeland S, Banchereau J. CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med 1997; 185:3419.
  • 33
    Arruda S & Ho JL. IL-4 receptor signal transduction in human monocytes is associated with protein kinase C translocation. J Immunol 1992; 149:125864.
  • 34
    Ren CL, Morio T, Fu SM, Geha RS. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2. J Exp Med 1994; 179:67380.
  • 35
    Mufson RA. The role of serine/threonine phosphorylation in hematopoietic cytokine receptor signal transduction. FASEB J 1997; 11:3744.